Do lipid parameters change during clomiphene citrate or letrozole therapy in women being treated for infertility? A pilot study

Eur J Obstet Gynecol Reprod Biol. 2021 Feb:257:151-152. doi: 10.1016/j.ejogrb.2020.12.010. Epub 2020 Dec 10.

Authors

Selma Amrane¹, Sally F Vitez², Katherine L Palmerola³, Roger A Lobo³

Affiliations

¹ Columbia University Medical Center, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, United States. Electronic address: selma.amrane@gmail.com.
² Columbia University Medical Center, Department of Obstetrics and Gynecology, United States.
³ Columbia University Medical Center, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, United States.

PMID: 33390278
DOI: 10.1016/j.ejogrb.2020.12.010

No abstract available

Publication types

Letter

MeSH terms

Aromatase Inhibitors / adverse effects
Clomiphene
Female
Fertility Agents, Female / adverse effects
Humans
Infertility*
Infertility, Female* / drug therapy
Letrozole
Lipids
Nitriles
Ovulation Induction
Pilot Projects
Polycystic Ovary Syndrome*

Substances

Aromatase Inhibitors
Fertility Agents, Female
Lipids
Nitriles
Clomiphene
Letrozole